Wang J - Search Results

1

Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC).

Yang G, Yao Y, Wu D, Guo H, Zhou S, Sun D, Guo X, Zheng T, Wang J, Zhang S, Wang Y, Song R, Ke S, Liu Y, Meng F, Liang Y, Lu Z, Liu L. Yang G, et al. Among authors: wang j, wang y. Life Sci. 2020 Dec 15;263:118576. doi: 10.1016/j.lfs.2020.118576. Epub 2020 Oct 12. Life Sci. 2020. PMID: 33058912

2

Role of microRNA in anticancer drug resistance.

Zheng T, Wang J, Chen X, Liu L. Zheng T, et al. Among authors: wang j. Int J Cancer. 2010 Jan 1;126(1):2-10. doi: 10.1002/ijc.24782. Int J Cancer. 2010. PMID: 19634138 Review.

3

Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.

Song X, Wang JB, Yin DL, Yang HY, Liu LX, Jiang HC. Song X, et al. Chin Med J (Engl). 2009 Nov 5;122(21):2636-42. Chin Med J (Engl). 2009. PMID: 19951584

4

Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.

Zheng T, Wang J, Song X, Meng X, Pan S, Jiang H, Liu L. Zheng T, et al. Among authors: wang j. J Cancer Res Clin Oncol. 2010 Oct;136(10):1597-604. doi: 10.1007/s00432-010-0817-8. Epub 2010 Feb 20. J Cancer Res Clin Oncol. 2010. PMID: 20174822

5

Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.

Zheng T, Wang J, Chen X, Meng X, Song X, Lu Z, Jiang H, Liu L. Zheng T, et al. Among authors: wang j. Tumour Biol. 2010 Aug;31(4):287-95. doi: 10.1007/s13277-010-0035-7. Epub 2010 Apr 27. Tumour Biol. 2010. PMID: 20422343

6

PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.

Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, Song X, Pan S, Jiang H, Liu L. Zheng T, et al. Among authors: wang j. J Cell Biochem. 2010 Sep 1;111(1):218-28. doi: 10.1002/jcb.22691. J Cell Biochem. 2010. PMID: 20506484

7

microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.

Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, Liu LX. Meng XZ, et al. J Gastroenterol Hepatol. 2011 Jan;26(1):186-93. doi: 10.1111/j.1440-1746.2010.06317.x. J Gastroenterol Hepatol. 2011. PMID: 21175813

8

Hippo signaling in oval cells and hepatocarcinogenesis.

Zheng T, Wang J, Jiang H, Liu L. Zheng T, et al. Among authors: wang j. Cancer Lett. 2011 Mar 28;302(2):91-9. doi: 10.1016/j.canlet.2010.12.008. Epub 2011 Jan 17. Cancer Lett. 2011. PMID: 21247686 Review.

9

MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.

Wang J, Zheng T, Chen X, Song X, Meng X, Bhatta N, Pan S, Jiang H, Liu L. Wang J, et al. J Gastroenterol Hepatol. 2011 Feb;26(2):371-7. doi: 10.1111/j.1440-1746.2010.06440.x. J Gastroenterol Hepatol. 2011. PMID: 21261729

10

Regulation of Fertility by the p53 Family Members.

Hu W, Zheng T, Wang J. Hu W, et al. Among authors: wang j. Genes Cancer. 2011 Apr;2(4):420-30. doi: 10.1177/1947601911408892. Genes Cancer. 2011. PMID: 21779510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,833 results

Search Page

Filters